三维/四维经会阴超声评估深部浸润型子宫内膜异位症伴浅表性交痛女性接受盆底肌物理治疗后的提肛肌裂孔面积:随机对照试验
该随机对照试验纳入34例深部浸润型子宫内膜异位症伴浅表性交痛的无分娩史女性,1:1随机分为对照组(无干预,17例)和盆底肌物理治疗组(5次个体化治疗,17例),4个月后复查三维/四维经会阴超声测量提肛肌裂孔面积及疼痛评分。完成研究的30例中,治疗组最大Valsalva动作时提肛肌裂孔面积变化百分比高于对照组,浅表性交痛和慢性盆腔痛NRS评分降低更明显。
要点
- 深部浸润型子宫内膜异位症伴浅表性交痛者,盆底肌物理治疗后最大Valsalva动作时提肛肌裂孔面积变化百分比高于对照组。
- 三维/四维经会阴超声可测量静息、最大盆底肌收缩和最大Valsalva动作时的提肛肌裂孔面积。
- 治疗组浅表性交痛NRS评分中位变化-3,对照组为0,组间差异有统计学意义。
核心结论
- 在深部浸润型子宫内膜异位症女性中,盆底肌物理治疗似乎可增加Valsalva动作时的提肛肌裂孔面积,并改善浅表性交痛、慢性盆腔痛和盆底肌放松。
研究设计与样本
- 随机对照试验,纳入34例诊断为深部浸润型子宫内膜异位症伴浅表性交痛的无分娩史女性,1:1随机分为对照组(无干预,17例)和研究组(5次个体化盆底肌物理治疗,17例)。
- 所有患者基线和4个月后均行三维/四维经会阴超声测量静息、最大盆底肌收缩和最大Valsalva动作时的提肛肌裂孔面积,并用数字评定量表(NRS)评估疼痛症状。
- 30例完成研究并纳入分析,其中研究组17例、对照组13例。
- 主要结局指标为基线与随访间最大Valsalva动作时提肛肌裂孔面积的变化百分比。
关键影像表现/征象
- 最大Valsalva动作时提肛肌裂孔面积变化百分比:研究组20.0 ± 24.8% vs 对照组-0.5 ± 3.3%,P = 0.02,提示研究组盆底肌放松更好。
诊断标准与关键数值
- 浅表性交痛NRS评分中位变化:对照组0(四分位距0-0) vs 研究组-3(四分位距-4至-2),P < 0.01。
- 慢性盆腔痛NRS评分中位变化:研究组0(四分位距-2至0) vs 对照组0(四分位距0-1),P = 0.01。
临床应用与阅片要点
- 对深部浸润型子宫内膜异位症伴浅表性交痛女性,可采用三维/四维经会阴超声于静息、最大盆底肌收缩和最大Valsalva动作时测量提肛肌裂孔面积,以评估盆底肌物理治疗后的盆底肌放松变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Deep infiltrating endometriosis (DIE) is associated with chronic pelvic pain, dyspareunia and pelvic floor muscle hypertonia. The primary aim of this study was to evaluate the effect of pelvic floor physiotherapy (PFP) on the area of levator ani hiatus during Valsalva maneuver, assessed using transperineal ultrasound, in women with DIE suffering from superficial dyspareunia.
METHODS: This was a randomized controlled trial of 34 nulliparous women diagnosed with DIE and associated superficial dyspareunia. After an initial clinical examination, all patients underwent three-dimensional/four-dimensional (3D/4D) transperineal ultrasound to measure the levator hiatal area (LHA) at rest, on maximum pelvic floor muscle contraction and on maximum Valsalva maneuver, and were asked to rate their pain symptoms using a numerical rating scale (NRS). Eligible women were assigned randomly (1:1 ratio) to no intervention (control group, 17 women) or treatment with five individual sessions of PFP (study group, 17 women). Four months after the first examination, all women underwent a second evaluation of pain symptoms and LHA on transperineal ultrasound. The primary outcome measure was the percentage change in LHA on maximum Valsalva maneuver between the baseline and follow-up examinations. The percentage changes in pain symptoms between the two examinations, including superficial and deep dyspareunia, dysmenorrhea, chronic pelvic pain, dysuria and dyschezia, were also evaluated.
RESULTS: Thirty women, comprising 17 in the study group and 13 in the control group, completed the study and were included in the analysis. The percentage change in LHA on maximum Valsalva maneuver between the two examinations was higher in the study group than in the control group (20.0 ± 24.8% vs -0.5 ± 3.3%; P = 0.02), indicating better pelvic floor muscle relaxation. After PFP treatment, the NRS score for superficial dyspareunia remained almost unchanged in the control group (median change in NRS (Δ-NRS), 0 (interquartile range (IQR), 0-0)) while a marked reduction was observed in the study group (median Δ-NRS, -3 (IQR, -4 to -2); P < 0.01). Moreover, there was a significant difference between the PFP and control groups with regards to the change in chronic pelvic pain (median Δ-NRS, 0 (IQR, -2 to 0) vs 0 (IQR, 0-1); P = 0.01).
CONCLUSIONS: In women with DIE, PFP seems to result in increased LHA on Valsalva maneuver, as observed by 3D/4D transperineal ultrasound, leading to improved superficial dyspareunia, chronic pelvic pain and pelvic floor muscle relaxation. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Del Forno S, Arena A, Pellizzone V, et al. Assessment of levator hiatal area using 3D/4D transperineal ultrasound in women with deep infiltrating endometriosis and superficial dyspareunia treated with pelvic floor muscle physiotherapy: randomized controlled trial. Ultrasound Obstet Gynecol. 2021. PMID: 33428320. doi:10.1002/uog.23590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。